Date/Time of Define-XML document generation: 2019-10-03T20:06:25
Define-XML version: 2.0.0
Stylesheet version: 2018-11-21
Datasets
| Dataset | Description | Class | Structure | Purpose | Keys | Documentation | Location |
|---|---|---|---|---|---|---|---|
| CO | Comments | SPECIAL PURPOSE | One record per comment | Tabulation | STUDYID, RDOMAIN, USUBJID, IDVAR, IDVARVAL, CODTC | co.xpt | |
| DM | Demographics | SPECIAL PURPOSE | One record per subject | Tabulation | STUDYID, USUBJID | dm.xpt | |
| SE | Subject Elements | SPECIAL PURPOSE | One record per element experienced per subject | Tabulation | STUDYID, USUBJID, ETCD, SESTDTC | se.xpt | |
| EX | Exposure | INTERVENTIONS | One record per constant dosing interval per treatment per subject or pool | Tabulation | STUDYID, USUBJID, EXTRT, EXSTDTC | ex.xpt | |
| DS | Disposition | EVENTS | One record per subject | Tabulation | STUDYID, USUBJID | ds.xpt | |
| BW | Body Weight | FINDINGS | One record per test per observation time per subject | Tabulation | STUDYID, USUBJID, BWTESTCD, BWDTC | bw.xpt | |
| BG | Body Weight Gains | FINDINGS | One record per test per interval per subject | Tabulation | STUDYID, USUBJID, BGTESTCD, BGDTC, BGENDTC | bg.xpt | |
| CL | Clinical Observations | FINDINGS | One record per finding per observation time per subject | Tabulation | STUDYID, USUBJID, CLTESTCD, CLCAT, CLORRES, CLLOC, CLDTC, CLSCAT, CLTPTNUM | cl.xpt | |
| LB | Laboratory | FINDINGS | One record per test per specimen per observation time per subject or pool | Tabulation | STUDYID, USUBJID, LBTESTCD, LBSPEC, LBDTC, LBTPTNUM, LBCAT, LBMETHOD, LBTPT | lb.xpt | |
| TA | Trial Arms | TRIAL DESIGN | One record per planned Element per Arm | Tabulation | STUDYID, ARMCD, TAETORD | ta.xpt | |
| TE | Trial Elements | TRIAL DESIGN | One record per planned Element | Tabulation | STUDYID, ETCD | te.xpt | |
| TX | Trial Sets | TRIAL DESIGN | One record per Trial Set parameter per Trial Set | Tabulation | STUDYID, SETCD, TXPARMCD | tx.xpt | |
| TS | Trial Summary | TRIAL DESIGN | One record per Trial Summary parameter value | Tabulation | STUDYID, TSPARMCD, TSGRPID | ts.xpt | |
| SUPPBW | Supplemental Body Weight (Body Weight) | RELATIONSHIP | One record per supplemental qualifier per related parent domain record(s) | Tabulation | STUDYID, RDOMAIN, USUBJID, IDVAR, IDVARVAL, QNAM | suppbw.xpt | |
| SUPPBG | Supplemental Body Weight Gain (Body Weight Gains) | RELATIONSHIP | One record per supplemental qualifier per related parent domain record(s) | Tabulation | STUDYID, RDOMAIN, USUBJID, IDVAR, IDVARVAL, QNAM | suppbg.xpt | |
| SUPPCL | Supplemental Clinical Observations (Clinical Observations) | RELATIONSHIP | One record per supplemental qualifier per related parent domain record(s) | Tabulation | STUDYID, RDOMAIN, USUBJID, IDVAR, IDVARVAL, QNAM | suppcl.xpt | |
| SUPPDS | Supplemental Disposition (Disposition) | RELATIONSHIP | One record per supplemental qualifier per related parent domain record(s) | Tabulation | STUDYID, RDOMAIN, USUBJID, IDVAR, IDVARVAL, QNAM | suppds.xpt | |
| SUPPLB | Supplemental Laboratory Test Results (Laboratory) | RELATIONSHIP | One record per supplemental qualifier per related parent domain record(s) | Tabulation | STUDYID, RDOMAIN, USUBJID, IDVAR, IDVARVAL, QNAM | supplb.xpt | |
| IS | Immunogenicity Specimen Assessments | FINDINGS | One record per test per specimen per observation time per subject or pool | Tabulation | STUDYID, USUBJID, ISTESTCD, ISDY | is.xpt | |
| SUPPIS | Supplemental Immunogenicity Specimen (Immunogenicity Specimen Assessments) | RELATIONSHIP | One record per supplemental qualifier per related parent domain record(s) | Tabulation | STUDYID, RDOMAIN, USUBJID, IDVAR, IDVARVAL | suppis.xpt |
Go to the top of the Define-XML document
Comments (CO)
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment |
|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | |
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER |
| RDOMAIN | Related Domain Abbreviation | text | Record Qualifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | |
| COSEQ | Sequence Number | integer | Identifier | 8 | OTHER | |
| IDVAR | Identifying Variable | text | Record Qualifier | 7 | OTHER | |
| IDVARVAL | Identifying Variable Value | text | Record Qualifier | 7 | OTHER | |
| COVAL | Comment | text | Topic | 10 | COLLECTED | |
| CODTC | Date/Time of Comment | datetime | Timing | ISO 8601 | COLLECTED | |
| CODY | Study Day of Comment | integer | Timing | 8 | DERIVED Calculated based on Date/Time of Observation minus Subject Reference Start Date/Time, plus one when occurring after Day 1.
|
Go to the top of the Define-XML document
Demographics (DM)
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment |
|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | |
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | |
| SUBJID | Subject Identifier for the Study | text | Topic | 6 | OTHER | |
| RFSTDTC | Subject Reference Start Date/Time | datetime | Record Qualifier | ISO 8601 | COLLECTED | |
| RFENDTC | Subject Reference End Date/Time | datetime | Record Qualifier | ISO 8601 | COLLECTED | |
| RFXSTDTC | Date/Time of First Study Treatment | datetime | Record Qualifier | ISO 8601 | COLLECTED | |
| RFXENDTC | Date/Time of Last Study Treatment | datetime | Record Qualifier | ISO 8601 | COLLECTED | |
| AGETXT | Age Range | text | Record Qualifier | 3 | OTHER | |
| AGEU | Age Unit | text | Variable Qualifier | 5 | Age Unit
| OTHER |
| SEX | Sex | text | Record Qualifier | 1 | Sex
| OTHER |
| ARMCD | Planned Arm Code | text | Record Qualifier | 1 | OTHER | |
| ARM | Description of Planned Arm | text | Synonym Qualifier | 4 | OTHER | |
| SETCD | Set Code | text | Record Qualifier | 1 | OTHER |
Go to the top of the Define-XML document
Subject Elements (SE)
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment |
|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | |
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | |
| SESEQ | Sequence Number | integer | Identifier | 8 | OTHER | |
| ETCD | Element Code | text | Topic | 5 | OTHER | |
| ELEMENT | Description of Element | text | Synonym Qualifier | 36 | OTHER | |
| SESTDTC | Start Date/Time of Element | datetime | Timing | ISO 8601 | COLLECTED | |
| SEENDTC | End Date/Time of Element | datetime | Timing | ISO 8601 | COLLECTED |
Go to the top of the Define-XML document
Exposure (EX)
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment |
|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | |
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | |
| EXSEQ | Sequence Number | integer | Identifier | 8 | OTHER | |
| EXTRT | Name of Actual Treatment | text | Topic | 19 | OTHER | |
| EXDOSE | Dose per Administration | float | Record Qualifier | 8 | COLLECTED | |
| EXDOSU | Dose Units | text | Variable Qualifier | 7 | Unit [14 Terms] | COLLECTED |
| EXDOSFRM | Dose Form | text | Variable Qualifier | 8 | Pharmaceutical Dosage Form
| OTHER |
| EXDOSFRQ | Dosing Frequency Per Interval | text | Variable Qualifier | 5 | Frequency
| OTHER |
| EXROUTE | Route of Administration | text | Variable Qualifier | 13 | Route of Administration Response
| OTHER |
| EXLOT | Lot Number | text | Record Qualifier | 5 | OTHER | |
| EXTRTV | Treatment Vehicle | text | Record Qualifier | 1 | OTHER | |
| EXSTDTC | Start Date/Time of Treatment | datetime | Timing | ISO 8601 | COLLECTED | |
| EXSTDY | Study Day of Start of Treatment | integer | Timing | 8 | DERIVED Calculated based on Date/Time of Observation minus Subject Reference Start Date/Time, plus one when occurring after Day 1.
|
Go to the top of the Define-XML document
Disposition (DS)
| Related Supplemental Qualifiers Dataset: SUPPDS (Supplemental Disposition) | |||||||
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment | |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | ||
| DSSEQ | Sequence Number | integer | Identifier | 8 | OTHER | ||
| DSTERM | Reported Term for the Disposition Event | text | Topic | 9 | COLLECTED | ||
| DSDECOD | Standardized Disposition Term | text | Synonym Qualifier | 24 | Standardized Disposition Term
| COLLECTED | |
| DSUSCHFL | Unscheduled Flag | text | Record Qualifier | 1 | No Yes Response
| OTHER | |
| VISITDY | Planned Study Day of Disposition | integer | Timing | 8 | DERIVED Calculated based on the planned date of data collection, in days from the Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| DSSTDTC | Date/Time of Disposition | datetime | Timing | ISO 8601 | COLLECTED | ||
| DSSTDY | Study Day of Disposition | integer | Timing | 8 | DERIVED Calculated based on Date/Time of Observation minus Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| DSNOMDY | Nominal Study Day for Tabulations | integer | Timing | 8 | DERIVED Calculated based on the planned date of data collection, in days from the Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
Go to the top of the Define-XML document
Body Weight (BW)
| Related Supplemental Qualifiers Dataset: SUPPBW (Supplemental Body Weight) | |||||||
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment | |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | ||
| BWSEQ | Sequence Number | integer | Identifier | 8 | OTHER | ||
| BWTESTCD | Test Short Name | text | Topic | 2 | Body Weight Test Code
| OTHER | |
| BWTEST | Test Name | text | Synonym Qualifier | 11 | Body Weight Test Name
| OTHER | |
| BWORRES | Result or Findings as Collected | text | Result Qualifier | 3 | COLLECTED | ||
| BWORRESU | Unit of the Original Result | text | Variable Qualifier | 2 | Unit [14 Terms] | COLLECTED | |
| BWSTRESC | Standardized Result in Character Format | text | Result Qualifier | 3 | COLLECTED | ||
| BWSTRESN | Standardized Result in Numeric Format | float | Result Qualifier | 8 | COLLECTED | ||
| BWSTRESU | Unit of the Standardized Result | text | Variable Qualifier | 2 | Unit [14 Terms] | COLLECTED | |
| BWBLFL | Baseline Flag | text | Record Qualifier | 1 | No Yes Response
| OTHER | |
| VISITDY | Planned Study Day of Collection | integer | Timing | 8 | DERIVED Calculated based on the planned date of data collection, in days from the Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| BWDTC | Date/Time Animal Weighed | datetime | Timing | ISO 8601 | COLLECTED | ||
| BWDY | Study Day Animal Weighed | integer | Timing | 8 | DERIVED Calculated based on Date/Time of Observation minus Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| BWNOMDY | Nominal Study Day for Tabulations | integer | Timing | 8 | DERIVED Calculated based on the planned date of data collection, in days from the Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| BWNOMLBL | Label for Nominal Study Day | text | Timing | 13 | DERIVED Populated with the phase name and the planned date of data collection, in days from the phase start date.
| ||
Go to the top of the Define-XML document
Body Weight Gains (BG)
| Related Supplemental Qualifiers Dataset: SUPPBG (Supplemental Body Weight Gain) | |||||||
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment | |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | ||
| BGSEQ | Sequence Number | integer | Identifier | 8 | OTHER | ||
| BGTESTCD | Test Short Name | text | Topic | 6 | Body Weight Gain Test Code
| OTHER | |
| BGTEST | Test Name | text | Synonym Qualifier | 16 | Body Weight Gain Test Name
| OTHER | |
| BGORRES | Result or Findings as Collected | text | Result Qualifier | 4 | COLLECTED | ||
| BGORRESU | Unit of the Original Result | text | Variable Qualifier | 2 | Unit [14 Terms] | COLLECTED | |
| BGSTRESC | Standardized Result in Character Format | text | Result Qualifier | 4 | COLLECTED | ||
| BGSTRESN | Standardized Result in Numeric Format | float | Result Qualifier | 8 | COLLECTED | ||
| BGSTRESU | Unit of the Standardized Result | text | Variable Qualifier | 2 | Unit [14 Terms] | COLLECTED | |
| BGDTC | Date/Time Animal Weighed | datetime | Timing | ISO 8601 | COLLECTED | ||
| BGENDTC | End Date/Time Animal Weighed | datetime | Timing | ISO 8601 | COLLECTED | ||
| BGDY | Study Day of Start of Interval | integer | Timing | 8 | DERIVED Calculated based on Date/Time of Observation minus Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| BGENDY | Study Day of End of Weight Interval | integer | Timing | 8 | DERIVED Calculated based on End Date/Time of Animal Weighed minus Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
Go to the top of the Define-XML document
Clinical Observations (CL)
| Related Supplemental Qualifiers Dataset: SUPPCL (Supplemental Clinical Observations) | |||||||
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment | |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | ||
| CLSEQ | Sequence Number | integer | Identifier | 8 | OTHER | ||
| CLGRPID | Group Identifier | text | Identifier | 7 | OTHER | ||
| CLTESTCD | Test Short Name | text | Topic | 5 | CLTESTCD
| OTHER | |
| CLTEST | Test Name | text | Synonym Qualifier | 20 | CLTEST
| OTHER | |
| CLCAT | Category for Clinical Observations | text | Grouping Qualifier | 14 | Category for Clinical Observation
| OTHER | |
| CLSCAT | Subcategory for Clinical Observations | text | Grouping Qualifier | 19 | CLSCAT
| OTHER | |
| CLORRES | Result or Findings as Collected | text | Result Qualifier | 50 | COLLECTED | ||
| CLSTRESC | Standardized Result in Character Format | text | Result Qualifier | 39 | COLLECTED | ||
| CLLOC | Location of a Finding | text | Record Qualifier | 16 | COLLECTED | ||
| VISITDY | Planned Study Day of Collection | integer | Timing | 8 | DERIVED Calculated based on the planned date of data collection, in days from the Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| CLDTC | Date/Time of Observation | datetime | Timing | ISO 8601 | COLLECTED | ||
| CLDY | Study Day of Observation | integer | Timing | 8 | DERIVED Calculated based on Date/Time of Observation minus Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| CLNOMDY | Nominal Study Day for Tabulations | integer | Timing | 8 | DERIVED Calculated based on the planned date of data collection, in days from the Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| CLNOMLBL | Label for Nominal Study Day | text | Timing | 13 | DERIVED Populated with the phase name and the planned date of data collection, in days from the phase start date.
| ||
| CLTPT | Planned Time Point Name | text | Timing | 9 | OTHER | ||
| CLTPTNUM | Planned Time Point Number | integer | Timing | 8 | OTHER | ||
Go to the top of the Define-XML document
Laboratory (LB)
| Related Supplemental Qualifiers Dataset: SUPPLB (Supplemental Laboratory Test Results) | |||||||
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment | |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | ||
| LBSEQ | Sequence Number | integer | Identifier | 8 | OTHER | ||
| LBGRPID | Group Identifier | text | Identifier | 7 | OTHER | ||
| LBREFID | Specimen Identifier | text | Identifier | 7 | OTHER | ||
| LBTESTCD | Lab Test or Examination Short Name | text | Topic | 8 | Laboratory Test Code [65 Terms] | OTHER | |
| LBTEST | Lab Test or Examination Name | text | Synonym Qualifier | 39 | Laboratory Test Name [65 Terms] | OTHER | |
| LBCAT | Category for Lab Test | text | Grouping Qualifier | 26 | LBCAT
| OTHER | |
| LBORRES | Result or Findings as Collected | text | Result Qualifier | 8 | COLLECTED | ||
| LBORRESU | Unit of the Original Result | text | Variable Qualifier | 7 | Unit [14 Terms] | COLLECTED | |
| LBSTRESC | Standardized Result in Character Format | text | Result Qualifier | 8 | COLLECTED | ||
| LBSTRESN | Standardized Result in Numeric Format | float | Result Qualifier | 8 | COLLECTED | ||
| LBSTRESU | Unit of the Standardized Result | text | Variable Qualifier | 7 | Unit [14 Terms] | COLLECTED | |
| LBSPEC | Specimen Material Type | text | Record Qualifier | 11 | Specimen
| OTHER | |
| LBSPCCND | Specimen Condition | text | Record Qualifier | 18 | OTHER | ||
| LBLOC | Specimen Collection Location | text | Record Qualifier | 12 | OTHER | ||
| LBMETHOD | Method of Test or Examination | text | Record Qualifier | 77 | OTHER | ||
| LBBLFL | Baseline Flag | text | Record Qualifier | 1 | No Yes Response
| OTHER | |
| LBUSCHFL | Unscheduled Flag | text | Record Qualifier | 1 | No Yes Response
| OTHER | |
| VISITDY | Planned Study Day of Collection | integer | Timing | 8 | DERIVED Calculated based on the planned date of data collection, in days from the Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| LBDTC | Date/Time of Specimen Collection | datetime | Timing | ISO 8601 | COLLECTED | ||
| LBDY | Study Day of Specimen Collection | integer | Timing | 8 | DERIVED Calculated based on Date/Time of Observation minus Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| LBNOMDY | Nominal Study Day for Tabulations | integer | Timing | 8 | DERIVED Calculated based on the planned date of data collection, in days from the Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| LBNOMLBL | Label for Nominal Study Day | text | Timing | 13 | DERIVED Populated with the phase name and the planned date of data collection, in days from the phase start date.
| ||
| LBTPT | Planned Time Point Name | text | Timing | 7 | OTHER | ||
| LBTPTNUM | Planned Time Point Number | integer | Timing | 8 | OTHER | ||
Go to the top of the Define-XML document
Trial Arms (TA)
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment |
|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | |
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER |
| ARMCD | Planned Arm Code | text | Topic | 1 | OTHER | |
| ARM | Description of Planned Arm | text | Synonym Qualifier | 4 | OTHER | |
| TAETORD | Order of Element within Arm | integer | Timing | 8 | OTHER | |
| ETCD | Element Code | text | Record Qualifier | 5 | OTHER | |
| ELEMENT | Description of Element | text | Synonym Qualifier | 36 | OTHER | |
| EPOCH | Trial Epoch | text | Timing | 7 | OTHER |
Go to the top of the Define-XML document
Trial Elements (TE)
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment |
|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | |
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER |
| ETCD | Element Code | text | Topic | 5 | OTHER | |
| ELEMENT | Description of Element | text | Synonym Qualifier | 36 | OTHER | |
| TESTRL | Rule for Start of Element | text | Rule | 19 | OTHER | |
| TEENRL | Rule for End of Element | text | Rule | 31 | OTHER | |
| TEDUR | Planned Duration of Element | text | Timing | 4 | OTHER |
Go to the top of the Define-XML document
Trial Sets (TX)
| Variable | Where Condition | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| SETCD | Set Code | text | Identifier | 1 | OTHER | ||
| SET | Set Description | text | Synonym Qualifier | 4 | OTHER | ||
| TXSEQ | Sequence Number | integer | Identifier | 8 | OTHER | ||
| TXPARMCD | Trial Set Parameter Short Name | text | Topic | 8 | SEND Trial Summary Parameter Test Code [38 Terms] | OTHER | |
| TXPARM | Trial Set Parameter | text | Synonym Qualifier | 33 | SEND Trial Summary Parameter Test Name [38 Terms] | OTHER | |
| TXVALVLM | Trial Set Parameter Value | text | Result Qualifier | 36 | OTHER | ||
| TXPARMCD = "SPGRPCD" (Alpha-numeric character(s) assigned by the sponsor to identify a particular collection of subjects possessing common characteristic(s).) | SPGRPCD | text | 200 | OTHER | |||
| TXPARMCD = "GRPLBL" (Alpha-numeric character(s) assigned to identify a particular collection of subjects possessing common characteristic(s).) | GRPLBL | text | 200 | OTHER |
Go to the top of the Define-XML document
Trial Summary (TS)
| Variable | Where Condition | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| TSSEQ | Sequence Number | integer | Identifier | 8 | OTHER | ||
| TSGRPID | Group Identifier | text | Identifier | 1 | OTHER | ||
| TSPARMCD | Trial Summary Parameter Short Name | text | Topic | 8 | SEND Trial Summary Parameter Test Code [38 Terms] | OTHER | |
| TSPARM | Trial Summary Parameter | text | Synonym Qualifier | 37 | SEND Trial Summary Parameter Test Name [38 Terms] | OTHER | |
| TSVALVLM | Parameter Value | text | Result Qualifier | 96 | OTHER | ||
| TSPARMCD = "STITLE" (The name of a nonclinical study.) | STITLE | text | 200 | OTHER | |||
| TSPARMCD = "TRT" (The investigational product under study.) | TRT | text | 200 | OTHER | |||
| TSPARMCD = "AGEU" (Those units of time that are routinely used to express the age of a person. (NCI)) | AGEU | text | 200 | Age Unit
| OTHER | ||
| TSPARMCD = "SDESIGN" (A plan detailing how a trial or study will be performed in order to represent the phenomenon under examination, to answer the research questions that have been asked, and defining the methods of data analysis. Study design is driven by the research hypothesis being posed, study subject/population/sample available, logistics/resources: technology, support, networking, collaborative support, etc.) | SDESIGN | text | 200 | Study Design
| OTHER | ||
| TSPARMCD = "ROUTE" (The course by which a substance is administered in order to reach the site of action in the body.) | ROUTE | text | 200 | Route of Administration Response
| OTHER | ||
| TSPARMCD = "SNDIGVER" (The version of the Standard for the Exchange of Nonclinical Data Implementation Guide that is being used in the study submission.) | SNDIGVER | text | 200 | SEND Implementation Guide Version
| OTHER | ||
| TSPARMCD = "SPECIES" (The common name for an animal used as the test system on a study (e.g., dog, monkey, mouse, rabbit, rat).) | SPECIES | text | 200 | Species
| OTHER | ||
| TSPARMCD = "SSTYP" (The type of nonclinical study performed e.g. Single Dose, Repeat Dose. (NCI)) | SSTYP | text | 200 | SEND Study Type
| OTHER | ||
| TSPARMCD = "STCAT" (The classification of the study. (NCI)) | STCAT | text | 200 | Study Category
| OTHER | ||
| TSPARMCD = "STRAIN" (The vendor-supplied species/strain/substrain designation for the test system under study. It may combine the species, background strain, substrain, and associated genetic modifications as supplied by the vendor (e.g. FISCHER 344, SPRAGUE-DAWLEY IGS, WISTAR Kyoto, BEAGLE, CYNOMOLGUS, RHESUS and CHIMPANZEE).) | STRAIN | text | 200 | Strain/Substrain
| OTHER | ||
| TSPARMCD = "TFCNTRY" (The country of the place in which a nonclinical laboratory study takes place, i.e., actually uses the test article in a test system. Testing facility includes any establishment required to register under section 510 of the act that conducts nonclinical laboratory studies and any consulting laboratory described in section 704 of the act that conducts such studies. Testing facility encompasses only those operational units that are being or have been used to conduct nonclinical laboratory studies. (FDA)) | TFCNTRY | text | 200 | Country
| OTHER | ||
| TSPARMCD = "SEXPOP" (The specific sex, either male, female, or mixed of the subject group being studied. (NCI)) | SEXPOP | text | 200 | Sex of Participants Response
| OTHER | ||
| TSVALNF | Parameter Null Flavor | text | Record Qualifier | 14 | Null Flavor Reason
| OTHER |
Go to the top of the Define-XML document
Supplemental Body Weight (SUPPBW)
| Related Parent Dataset: BW (Body Weight) | |||||||
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment | |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| RDOMAIN | Related Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | ||
| IDVAR | Identifying Variable | text | Record Qualifier | 5 | OTHER | ||
| IDVARVAL | Identifying Variable Value | text | Record Qualifier | 2 | OTHER | ||
| QNAM | Qualifier Variable Name | text | Identifier | 8 | OTHER | ||
| QLABEL | Qualifier Variable Label | text | Identifier | 12 | OTHER | ||
| QVALVLM | Data Value | text | Record Qualifier | 7 | OTHER | ||
➤ QNAM = "PHSENAME" | PHSENAME | text | 64 | OTHER | |||
➤ QNAM = "PHASEDAY" | PHASEDAY | integer | 3 | OTHER | |||
| QORIG | Origin | text | Record Qualifier | 9 | OTHER | ||
Go to the top of the Define-XML document
Supplemental Body Weight Gain (SUPPBG)
| Related Parent Dataset: BG (Body Weight Gains) | |||||||
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment | |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| RDOMAIN | Related Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | ||
| IDVAR | Identifying Variable | text | Record Qualifier | 5 | OTHER | ||
| IDVARVAL | Identifying Variable Value | text | Record Qualifier | 2 | OTHER | ||
| QNAM | Qualifier Variable Name | text | Identifier | 8 | OTHER | ||
| QLABEL | Qualifier Variable Label | text | Identifier | 18 | OTHER | ||
| QVALVLM | Data Value | text | Record Qualifier | 7 | OTHER | ||
➤ QNAM = "PHSNAME2" | PHSNAME2 | text | 64 | OTHER | |||
➤ QNAM = "PHSEDAY2" | PHSEDAY2 | integer | 3 | OTHER | |||
| QORIG | Origin | text | Record Qualifier | 9 | OTHER | ||
Go to the top of the Define-XML document
Supplemental Clinical Observations (SUPPCL)
| Related Parent Dataset: CL (Clinical Observations) | |||||||
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment | |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| RDOMAIN | Related Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | ||
| IDVAR | Identifying Variable | text | Record Qualifier | 5 | OTHER | ||
| IDVARVAL | Identifying Variable Value | text | Record Qualifier | 2 | OTHER | ||
| QNAM | Qualifier Variable Name | text | Identifier | 8 | OTHER | ||
| QLABEL | Qualifier Variable Label | text | Identifier | 12 | OTHER | ||
| QVALVLM | Data Value | text | Record Qualifier | 7 | OTHER | ||
➤ QNAM = "PHSENAME" | PHSENAME | text | 64 | OTHER | |||
➤ QNAM = "PHASEDAY" | PHASEDAY | integer | 3 | OTHER | |||
| QORIG | Origin | text | Record Qualifier | 9 | OTHER | ||
Go to the top of the Define-XML document
Supplemental Disposition (SUPPDS)
| Related Parent Dataset: DS (Disposition) | |||||||
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment | |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| RDOMAIN | Related Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | ||
| IDVAR | Identifying Variable | text | Record Qualifier | 5 | OTHER | ||
| IDVARVAL | Identifying Variable Value | text | Record Qualifier | 1 | OTHER | ||
| QNAM | Qualifier Variable Name | text | Identifier | 8 | OTHER | ||
| QLABEL | Qualifier Variable Label | text | Identifier | 12 | OTHER | ||
| QVALVLM | Data Value | text | Record Qualifier | 6 | OTHER | ||
➤ QNAM = "PHSENAME" | PHSENAME | text | 64 | OTHER | |||
➤ QNAM = "PHASEDAY" | PHASEDAY | integer | 3 | OTHER | |||
| QORIG | Origin | text | Record Qualifier | 9 | OTHER | ||
Go to the top of the Define-XML document
Supplemental Laboratory Test Results (SUPPLB)
| Related Parent Dataset: LB (Laboratory) | |||||||
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment | |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| RDOMAIN | Related Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | ||
| IDVAR | Identifying Variable | text | Record Qualifier | 5 | OTHER | ||
| IDVARVAL | Identifying Variable Value | text | Record Qualifier | 3 | OTHER | ||
| QNAM | Qualifier Variable Name | text | Identifier | 8 | OTHER | ||
| QLABEL | Qualifier Variable Label | text | Identifier | 12 | OTHER | ||
| QVALVLM | Data Value | text | Record Qualifier | 7 | OTHER | ||
➤ QNAM = "PHSENAME" | PHSENAME | text | 64 | OTHER | |||
➤ QNAM = "PHASEDAY" | PHASEDAY | integer | 3 | OTHER | |||
| QORIG | Origin | text | Record Qualifier | 9 | OTHER | ||
Go to the top of the Define-XML document
Immunogenicity Specimen Assessments (IS)
| Related Supplemental Qualifiers Dataset: SUPPIS (Supplemental Immunogenicity Specimen) | |||||||
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment | |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| DOMAIN | Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | ||
| ISSEQ | Sequence Number | integer | Identifier | 8 | OTHER | ||
| ISTESTCD | Immunogenicity Test/Exam Short Name | text | Topic | 8 | ISTESTCD
| OTHER | |
| ISTEST | Immunogenicity Test or Examination Name | text | Synonym Qualifier | 39 | ISTEST
| OTHER | |
| ISCAT | Category for Immunogenicity Test | text | Grouping Qualifier | 26 | OTHER | ||
| ISORRES | Result or Findings as Collected | text | Result Qualifier | 8 | COLLECTED | ||
| ISORRESU | Original Units | text | Variable Qualifier | 7 | COLLECTED | ||
| ISSTRESC | Standardized Result in Character Format | text | Result Qualifier | 8 | COLLECTED | ||
| ISSTRESN | Standardized Result in Numeric Format | float | Result Qualifier | 8 | COLLECTED | ||
| ISSTRESU | Standard Units | text | Variable Qualifier | 7 | IS.UNIT
| COLLECTED | |
| ISSPEC | Specimen Material Type | text | Record Qualifier | 11 | Specimen
| OTHER | |
| ISLOC | Specimen Collection Location | text | Record Qualifier | 12 | OTHER | ||
| ISMETHOD | Method of Test or Examination | text | Record Qualifier | 77 | OTHER | ||
| ISBLFL | Baseline Flag | text | Record Qualifier | 1 | No Yes Response
| DERIVED Last non-null predose observation per subject per test | |
| ISFAST | Fasting Status | text | 1 | No Yes Response
| OTHER | ||
| ISLLOQ | Lower Limit of Quantitation | integer | 3 | OTHER | |||
| ISUSCHFL | Unscheduled Flag | text | Record Qualifier | 1 | No Yes Response
| OTHER | |
| ISDTC | Date/Time of Specimen Collection | datetime | Timing | ISO 8601 | COLLECTED | ||
| ISDY | Study Day of Specimen Collection | integer | Timing | 8 | DERIVED Calculated based on Date/Time of Observation minus Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| ISNOMDY | Nominal Study Day for Tabulations | integer | Timing | 8 | DERIVED Calculated based on the planned date of data collection, in days from the Subject Reference Start Date/Time, plus one when occurring after Day 1.
| ||
| ISNOMLBL | Label for Nominal Study Day | text | Timing | 13 | DERIVED Populated with the phase name and the planned date of data collection, in days from the phase start date.
| ||
Go to the top of the Define-XML document
Supplemental Immunogenicity Specimen (SUPPIS)
| Related Parent Dataset: IS (Immunogenicity Specimen Assessments) | |||||||
| Variable | Label / Description | Type | Role | Length or Display Format | Controlled Terms or ISO Format | Origin / Source / Method / Comment | |
|---|---|---|---|---|---|---|---|
| STUDYID | Study Identifier | text | Identifier | 7 | OTHER | ||
| RDOMAIN | Related Domain Abbreviation | text | Identifier | 2 | SEND Domain Abbreviation [14 Terms] | OTHER | |
| USUBJID | Unique Subject Identifier | text | Identifier | 14 | OTHER | ||
| IDVAR | Identifying Variable | text | Record Qualifier | 5 | OTHER | ||
| IDVARVAL | Identifying Variable Value | text | Record Qualifier | 2 | OTHER | ||
| QNAM | Qualifier Variable Name | text | Identifier | 8 | OTHER | ||
| QLABEL | Qualifier Variable Label | text | Identifier | 12 | OTHER | ||
| QVALVLM | Data Value | text | Record Qualifier | 7 | OTHER | ||
➤ QNAM = "PHSENAME" | PHSENAME | text | 64 | OTHER | |||
➤ QNAM = "PHASEDAY" | PHASEDAY | integer | 3 | OTHER | |||
| QORIG | Origin | text | Record Qualifier | 9 | OTHER | ||
Go to the top of the Define-XML document
CodeLists
| Permitted Value (Code) |
|---|
| YEARS [C29848] |
| Permitted Value (Code) |
|---|
| Body Weight Gain [C62754] |
| Permitted Value (Code) | Display Value (Decode) |
|---|---|
| BWGAIN [C62754] | A change in overall body weight, relative to the beginning of the collection period. |
| Permitted Value (Code) |
|---|
| Body Weight [C81328] |
| Permitted Value (Code) | Display Value (Decode) |
|---|---|
| BW [C81328] | The weight of a subject. (NCI) |
| Permitted Value (Code) |
|---|
| CLINICAL SIGNS [C100104] |
| Permitted Value (Code) |
|---|
| Discharge [*] |
| Excretion [*] |
| Physical Appearance [*] |
| Vet Exam [*] |
* Extended Value
| Permitted Value (Code) |
|---|
| Clinical Observation [*] |
* Extended Value
| Permitted Value (Code) | Display Value (Decode) |
|---|---|
| CLNOB [*] | An assessment of clinical observations. |
* Extended Value
| Permitted Value (Code) |
|---|
| USA [C17234] |
| Permitted Value (Code) |
|---|
| PARALLEL [C82639] |
| Permitted Value (Code) |
|---|
| REMOVED FROM STUDY ALIVE [C90447] |
| Permitted Value (Code) |
|---|
| TWICE [C65134] |
| Permitted Value (Code) |
|---|
| SOLUTION [C42986] |
| Permitted Value (Code) |
|---|
| CLINICAL CHEMISTRY [*] |
| COAGULATION [*] |
| HEMATOLOGY [*] |
| URINALYSIS/URINE CHEMISTRY [*] |
* Extended Value
| Permitted Value (Code) |
|---|
| Activated Partial Thromboplastin Time [C38462] |
| Alanine Aminotransferase [C64433] |
| Albumin [C64431] |
| Albumin/Globulin [C74894] |
| Alkaline Phosphatase [C64432] |
| Anisocytes [C74797] |
| Aspartate Aminotransferase [C64467] |
| Bacteria [C64469] |
| Basophils [C64470] |
| Basophils/Leukocytes [C64471] |
| Bilirubin [C38037] |
| Calcium [C64488] |
| Casts [C74763] |
| Chloride [C64495] |
| Cholesterol [C105586] |
| Clarity [C96594] |
| Color [C64546] |
| Creatine Kinase [C64489] |
| Creatinine [C64547] |
| Crystals [C74673] |
| Direct Bilirubin [C64481] |
| Eosinophils [C64550] |
| Eosinophils/Leukocytes [C64604] |
| Epithelial Cells [C64605] |
| Ery. Mean Corpuscular HGB Concentration [C64798] |
| Ery. Mean Corpuscular Hemoglobin [C64797] |
| Ery. Mean Corpuscular Volume [C64799] |
| Erythrocytes [C51946] |
| Gamma Glutamyl Transferase [C64847] |
| Globulin [C74738] |
| Glucose [C105585] |
| Hematocrit [C64796] |
| Hemoglobin [C64848] |
| Hypochromia [C64802] |
| Ketones [C64854] |
| Large Unstained Cells [C74659] |
| Large Unstained Cells/Leukocytes [C79467] |
| Leukocytes [C51948] |
| Lymphocytes [C51949] |
| Lymphocytes/Leukocytes [C64820] |
| Monocytes [C64823] |
| Monocytes/Leukocytes [C64824] |
| Neutrophils [C63321] |
| Neutrophils/Leukocytes [C64827] |
| Occult Blood [C74686] |
| Other Urine Microscopic Findings [*] |
| Phosphate [C64857] |
| Platelets [C51951] |
| Poikilocytes [C79602] |
| Polychromasia [C64803] |
| Potassium [C64853] |
| Protein [C64858] |
| Prothrombin Time [C62656] |
| Reticulocytes [C51947] |
| Reticulocytes/Erythrocytes [C64828] |
| Sodium [C64809] |
| Specific Gravity [C64832] |
| Toxic Granulation [C96641] |
| Triglycerides [C64812] |
| Unclassified Casts [C74776] |
| Unclassified Crystals [C74757] |
| Urea Nitrogen [C125949] |
| Urobilinogen [C64816] |
| Volume [C74720] |
| pH [C45997] |
* Extended Value
| Permitted Value (Code) | Display Value (Decode) |
|---|---|
| ALB [C64431] | A measurement of the albumin protein in a biological specimen. |
| ALBGLOB [C74894] | The ratio of albumin to globulin in a biological specimen. |
| ALP [C64432] | A measurement of the alkaline phosphatase in a biological specimen. |
| ALT [C64433] | A measurement of the alanine aminotransferase in a biological specimen. |
| ANISO [C74797] | A measurement of the variability in the size of the red blood cells in a whole blood specimen. |
| APTT [C38462] | A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture. |
| AST [C64467] | A measurement of the aspartate aminotransferase in a biological specimen. |
| BACT [C64469] | A measurement of the bacteria in a biological specimen. |
| BASO [C64470] | A measurement of the basophils in a biological specimen. |
| BASOLE [C64471] | A relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen. |
| BILDIR [C64481] | A measurement of the conjugated or water-soluble bilirubin in a biological specimen. |
| BILI [C38037] | A measurement of the total bilirubin in a biological specimen. |
| CA [C64488] | A measurement of the calcium in a biological specimen. |
| CASTS [C74763] | A statement that indicates casts were looked for in a biological specimen. |
| CHOL [C105586] | A measurement of the cholesterol in a biological specimen. |
| CK [C64489] | A measurement of the total creatine kinase in a biological specimen. |
| CL [C64495] | A measurement of the chloride in a biological specimen. |
| CLARITY [C96594] | A measurement of the transparency of a biological specimen. |
| COLOR [C64546] | A measurement of the color of a biological specimen. |
| CREAT [C64547] | A measurement of the creatinine in a biological specimen. |
| CRYSTALS [C74673] | A statement that indicates crystals were looked for in a biological specimen. |
| CSUNCLA [C74776] | A measurement of the unclassifiable casts present in a biological specimen. |
| CYUNCLA [C74757] | A measurement of the unclassifiable crystals present in a biological specimen. |
| EOS [C64550] | A measurement of the eosinophils in a biological specimen. |
| EOSLE [C64604] | A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen. |
| EPIC [C64605] | A measurement of the epithelial cells in a biological specimen. |
| GGT [C64847] | A measurement of the gamma glutamyl transferase in a biological specimen. |
| GLOBUL [C74738] | A measurement of the globulin protein in a biological specimen. |
| GLUC [C105585] | A measurement of the glucose in a biological specimen. |
| HCT [C64796] | The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes). |
| HGB [C64848] | A measurement of the total erythrocyte associated hemoglobin in a biological specimen. |
| HPOCROM [C64802] | An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level. |
| K [C64853] | A measurement of the potassium in a biological specimen. |
| KETONES [C64854] | A measurement of the ketones in a biological specimen. |
| LGLUCLE [C79467] | A relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen. |
| LGUNSCE [C74659] | A measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen. |
| LYM [C51949] | A measurement of the lymphocytes in a biological specimen. |
| LYMLE [C64820] | A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen. |
| MCH [C64797] | A measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen, calculated as the product of hemoglobin times ten, divided by the number of erythrocytes. |
| MCHC [C64798] | An indirect measurement of the average concentration of hemoglobin per erythrocyte in a biological specimen, calculated as the ratio of hemoglobin to hematocrit. |
| MCV [C64799] | A measurement of the mean cellular volume per erythrocyte in a biological specimen. |
| MONO [C64823] | A measurement of the monocytes in a biological specimen. |
| MONOLE [C64824] | A relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen. |
| NEUT [C63321] | A measurement of the neutrophils in a biological specimen. |
| NEUTLE [C64827] | A relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen. |
| OCCBLD [C74686] | A measurement of the blood in body products such as a urine or stool sample, not detectable on gross examination. |
| OTHR [*] | Sperm was observed as present in the urine sample during a microscopic examination. |
| PH [C45997] | The negative logarithm (base 10) of the concentration of hydronium ions, which is used as a measure of the acidity or alkalinity of a fluid. |
| PHOS [C64857] | A measurement of the phosphate in a biological specimen. |
| PLAT [C51951] | A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. |
| POIKILO [C79602] | A measurement of the odd-shaped erythrocytes in a whole blood specimen. |
| POLYCHR [C64803] | A measurement of the blue-staining characteristic of newly generated erythrocytes. |
| PROT [C64858] | A measurement of the total protein in a biological specimen. |
| PT [C62656] | A blood clotting measurement that evaluates the extrinsic pathway of coagulation. |
| RBC [C51946] | A measurement of the total erythrocytes in a biological specimen. |
| RETI [C51947] | A measurement of the reticulocytes in a biological specimen. |
| RETIRBC [C64828] | A relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen. |
| SODIUM [C64809] | A measurement of the sodium in a biological specimen. |
| SPGRAV [C64832] | A ratio of the density of a fluid to the density of water. |
| TOXGRAN [C96641] | A measurement of the toxic granulation in granulocytic blood cells. |
| TRIG [C64812] | A measurement of the triglycerides in a biological specimen. |
| UREAN [C125949] | A measurement of the urea nitrogen in a biological specimen. |
| UROBIL [C64816] | A measurement of the urobilinogen in a biological specimen. |
| VOLUME [C74720] | A measurement of the volume of a biological specimen. |
| WBC [C51948] | A measurement of the leukocytes in a biological specimen. |
* Extended Value
| Permitted Value (Code) |
|---|
| MASKED [C150904] |
| NOT APPLICABLE [C48660] |
| UNKNOWN [C17998] |
| Permitted Value (Code) | Display Value (Decode) |
|---|---|
| Y [C49488] [*] | Yes |
* Extended Value
| Permitted Value (Code) |
|---|
| INTRAMUSCULAR [C28161] |
| Permitted Value (Code) | Display Value (Decode) |
|---|---|
| BG [C95083] | Body weight gain is the actual difference between two body weight measurements for any given interval for a subject. This is most commonly shown as the difference between two consecutive body weight measurements. |
| BW [C95085] | This domain captures body weights collected for subjects during the study and at the end of the study (terminal body weights). |
| CL [C95086] | This domain captures clinical sign information including ophthalmology, physical examination, and dermal examination collected in life while executing the study. |
| CO [C49569] | A special-purpose domain that contains comments that may be collected alongside other data. |
| DM [C49572] | A special-purpose domain that includes a set of essential standard variables that describe each subject in a clinical study. It is the parent domain for all other observations for human clinical subjects. |
| DS [C49576] | An events domain that contains information encompassing and representing data related to subject disposition. |
| EX [C49587] | An interventions domain that contains the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject. |
| LB [C49592] | A findings domain that contains laboratory test data such as hematology, clinical chemistry and urinalysis. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains. |
| SE [C49616] | A special-purpose domain that contains the actual order of elements followed by the subject, together with the start date/time and end date/time for each element. |
| TA [C49618] | A trial design domain that contains each planned arm in the trial. |
| TE [C49619] | A trial design domain that contains the element code that is unique for each element, the element description, and the rules for starting and ending an element. |
| TS [C53483] | A trial design domain that contains one record for each trial summary characteristic. This domain is not subject oriented. |
| TX [C95103] | A trial design domain that contains one record for each trial set characteristic including experimental factors, treatment factors, inherent characteristics, or distinct sponsor designations. This domain is not subject oriented. |
| IS [*] | A findings domain for assessments that determine whether a therapy induced an immune response. |
* Extended Value
| Permitted Value (Code) | Display Value (Decode) |
|---|---|
| F [C16576] | A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI) |
| Permitted Value (Code) | Display Value (Decode) |
|---|---|
| F [C16576] | A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI) |
| Permitted Value (Code) |
|---|
| SEND IMPLEMENTATION GUIDE VERSION 3.1 [C120925] |
| Permitted Value (Code) |
|---|
| PLASMA [C13356] |
| SERUM [C13325] |
| URINE [C13283] |
| WHOLE BLOOD [C41067] |
| Permitted Value (Code) |
|---|
| MONKEY [C14243] |
| Permitted Value (Code) |
|---|
| REPEAT DOSE TOXICITY [C79376] |
| Permitted Value (Code) |
|---|
| TOX [C17206] |
| Permitted Value (Code) |
|---|
| CYNOMOLGUS [C14232] |
| Permitted Value (Code) |
|---|
| Age Text [C90352] |
| Age Unit [C50400] |
| Arm Code [C83216] |
| Dose Level [C25488] |
| Dose Units [C73558] |
| Dosing Duration [C90378] |
| Experimental End Date [C90382] |
| Experimental Start Date [C90487] |
| Good Laboratory Practice Type [C90389] |
| Group Label [C90391] |
| Housing Group [C90394] |
| Investigational Therapy or Treatment [C41161] |
| Planned Number of Female Subjects [C90437] |
| Planned Number of Subjects [C95106] |
| Primary Treatment CAS Registry Number [C92645] |
| Route of Administration [C38114] |
| SEND Controlled Terminology Version [C96370] |
| SEND Implementation Guide Version [C90458] |
| Sex of Participants [C49696] |
| Species [C96433] |
| Sponsor's Study Reference ID [C135009] |
| Sponsor-Defined Group Code [C90456] |
| Sponsoring Organization [C129946] |
| Strain/Substrain [C96373] |
| Study Category [C90461] |
| Study Design [C95082] |
| Study Director [C129944] |
| Study End Date [C99156] |
| Study Length [C95105] |
| Study Start Date [C99157] |
| Study Title [C95108] |
| Study Type [C92644] |
| Test Facility Country [C90467] |
| Test Facility Location [C90468] |
| Test Facility Name [C90469] |
| Test Subject Supplier [C90473] |
| Time to Terminal Sacrifice [C90466] |
| Treatment Vehicle [C927] |
| Permitted Value (Code) | Display Value (Decode) |
|---|---|
| AGETXT [C90352] | A textual representation of a chronological age. (NCI) |
| AGEU [C50400] | Those units of time that are routinely used to express the age of a person. (NCI) |
| ARMCD [C83216] | A character or string that represents a planned arm of a trial or study. |
| DOSDUR [C90378] | The interval of time over which a course of doses occurs. (NCI) |
| EXPENDTC [C90382] | Experimental completion date means the last date on which data are collected from the study. (OECD) |
| EXPSTDTC [C90487] | Experimental starting date means the date on which the first study specific data are collected. (OECD) |
| GLPTYP [C90389] | A quality system concerned with the organizational process and the conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, archived and reported. (OECD) |
| GRPLBL [C90391] | Alpha-numeric character(s) assigned to identify a particular collection of subjects possessing common characteristic(s). |
| HOUSEGRP [C90394] | A classification of a group of animals based upon their shared living space. |
| PLANFSUB [C90437] | The intended quantity of female subjects. |
| ROUTE [C38114] | The course by which a substance is administered in order to reach the site of action in the body. |
| SDESIGN [C95082] | A plan detailing how a trial or study will be performed in order to represent the phenomenon under examination, to answer the research questions that have been asked, and defining the methods of data analysis. Study design is driven by the research hypothesis being posed, study subject/population/sample available, logistics/resources: technology, support, networking, collaborative support, etc. |
| SEXPOP [C49696] | The specific sex, either male, female, or mixed of the subject group being studied. (NCI) |
| SLENGTH [C95105] | The anticipated length of a nonclinical study measured as a unit of time. (NCI) |
| SNDCTVER [C96370] | The version of the Standard for the Exchange of Nonclinical Data Controlled Terminology that is being used in the study. |
| SNDIGVER [C90458] | The version of the Standard for the Exchange of Nonclinical Data Implementation Guide that is being used in the study submission. |
| SPECIES [C96433] | The common name for an animal used as the test system on a study (e.g., dog, monkey, mouse, rabbit, rat). |
| SPGRPCD [C90456] | Alpha-numeric character(s) assigned by the sponsor to identify a particular collection of subjects possessing common characteristic(s). |
| SPLANSUB [C95106] | The planned number of subjects to be entered in a nonclinical study. |
| SPLRNAM [C90473] | The name of the organization that supplied the test subjects. (NCI) |
| SPREFID [C135009] | The reference identifier by which the study is known to the sponsor. This may be different from the STUDYID if the data were collected under a different identifier in the GLP protocol (e.g., used in a situation where a contract facility performs the study and provides a final report). |
| SSPONSOR [C129946] | The name of the entity that is responsible for the initiation, management, and/or financing of a nonclinical study. (NCI) |
| SSTYP [C92644] | The type of nonclinical study performed e.g. Single Dose, Repeat Dose. (NCI) |
| STCAT [C90461] | The classification of the study. (NCI) |
| STDIR [C129944] | The name of the person who has overall responsibility for the technical conduct of a study, as well as for the interpretation, analysis, documentation and reporting of results, and represents the single point of study control. (FDA) |
| STENDTC [C99156] | The date on which the final report is signed by the study director. Also known as Study Completion Date. (FDA) |
| STITLE [C95108] | The name of a nonclinical study. |
| STRAIN [C96373] | The vendor-supplied species/strain/substrain designation for the test system under study. It may combine the species, background strain, substrain, and associated genetic modifications as supplied by the vendor (e.g. FISCHER 344, SPRAGUE-DAWLEY IGS, WISTAR Kyoto, BEAGLE, CYNOMOLGUS, RHESUS and CHIMPANZEE). |
| STSTDTC [C99157] | The date on which the protocol is signed by the study director. Also known as Study Initiation Date. (FDA) |
| TFCNTRY [C90467] | The country of the place in which a nonclinical laboratory study takes place, i.e., actually uses the test article in a test system. Testing facility includes any establishment required to register under section 510 of the act that conducts nonclinical laboratory studies and any consulting laboratory described in section 704 of the act that conducts such studies. Testing facility encompasses only those operational units that are being or have been used to conduct nonclinical laboratory studies. (FDA) |
| TRMSAC [C90466] | The duration from the start of dosing to the final sacrifice of the subject. (NCI) |
| TRT [C41161] | The investigational product under study. |
| TRTCAS [C92645] | The Chemical Abstract Service registry number of the investigational product (test article). |
| TRTDOS [C25488] | The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary) |
| TRTDOSU [C73558] | The unit of measure for the dosage form. |
| TRTV [C927] | A carrier or inert medium used as a solvent (or diluent) in which a medicinally active agent is formulated and or administered. (NCI) |
| TSTFLOC [C90468] | The geographic area of the place in which a nonclinical laboratory study takes place, i.e., actually uses the test article in a test system. Testing facility includes any establishment required to register under section 510 of the act that conducts nonclinical laboratory studies and any consulting laboratory described in section 704 of the act that conducts such studies. Testing facility encompasses only those operational units that are being or have been used to conduct nonclinical laboratory studies. (FDA) |
| TSTFNAM [C90469] | The name of the place in which a nonclinical laboratory study takes place, i.e., actually uses the test article in a test system. Testing facility includes any establishment required to register under section 510 of the act that conducts nonclinical laboratory studies and any consulting laboratory described in section 704 of the act that conducts such studies. Testing facility encompasses only those operational units that are being or have been used to conduct nonclinical laboratory studies. (FDA) |
| Permitted Value (Code) |
|---|
| % [C25613] |
| 10^12/L [C67308] |
| 10^9/L [C67255] |
| U/L [C67456] |
| fL [C64780] |
| g [C48155] |
| g/dL [C64783] |
| kg [C28252] |
| mL [C28254] |
| mg/dL [C67015] |
| mmol/L [C64387] |
| pg [C64551] |
| sec [C42535] |
| ug/dose [C124462] |
| Permitted Value (Code) |
|---|
| HBsAg IgM |
| HBsAg IgG |
| Permitted Value (Code) | Display Value (Decode) |
|---|---|
| IGMHBA | Hepatitis B Vaccine (HBsAg) IgM Serum Analysis |
| IGGHBA | Hepatitis B Vaccine (HBsAg) IgG Serum Analysis |
| Permitted Value (Code) |
|---|
| U/mL [C124462] |
Go to the top of the Define-XML document
Methods
| Method | Type | Description |
|---|---|---|
| VISITDY | Computation | Calculated based on the planned date of data collection, in days from the Subject Reference Start Date/Time, plus one when occurring after Day 1.
|
| BLFL | Computation | Last non-null predose observation per subject per test |
| ENDY | Computation | Calculated based on End Date/Time of Animal Weighed minus Subject Reference Start Date/Time, plus one when occurring after Day 1.
|
| DY | Computation | Calculated based on Date/Time of Observation minus Subject Reference Start Date/Time, plus one when occurring after Day 1.
|
| NOMLBL | Computation | Populated with the phase name and the planned date of data collection, in days from the phase start date.
|
| NOMDY | Computation | Calculated based on the planned date of data collection, in days from the Subject Reference Start Date/Time, plus one when occurring after Day 1.
|
Go to the top of the Define-XML document